Choosing the best site to inject Wegovy

What the choice actually comes down to

Picking an injection site is not a clinical technicality, it is a practical decision you make in your bathroom or kitchen every week for as long as you are on treatment. The three options the Wegovy licence permits are the abdomen (belly), the front and outer thigh, and the upper outer arm. None of them is pharmacologically superior to the others. The meaningful differences are about comfort, accessibility, and what the skin at each site looks like week to week.

Start by asking yourself the most basic question: can I reach it easily, and can I pinch enough tissue to inject safely? For most people, the abdomen is the most intuitive starting point. There is usually plenty of soft tissue, the angle is easy to see and control, and you can do it sitting down. The thigh is a good alternative, particularly if you find the abdomen uncomfortable after a dose increase. The upper arm is the trickiest for solo injectors; a partner or nurse can help, but if you are always alone at injection time, it is worth practising one of the other two first.

One practical note: if you tend to inject on a particular day (a Monday-morning routine before the week starts, say, or a Friday that suits your schedule) consistency with the day matters more than which site you used last week. Lock in the day, then rotate the site around it.

Rotating sites: the rule that protects your skin

Repeated injections into exactly the same square centimetre of skin cause a condition called lipohypertrophy, a thickening and hardening of the subcutaneous fat. Tissue that has developed lipohypertrophy absorbs medicine unpredictably. You will not necessarily notice a problem immediately, but absorption of the active ingredient can become erratic over time, which undermines the steady weekly plasma level semaglutide depends on.

The practical answer is rotation. Within any one site (the abdomen, for example) move at least two to three centimetres from your last injection point before you inject again. Across weeks, consider cycling between sites: abdomen one week, thigh the next, then back. A simple pattern is easier to remember than a precise map. Some people find it helpful to keep a brief note in their phone, or use their Wegovy pen's built-in dose counter as a prompt.

Avoid the two centimetres immediately around the navel, and steer well clear of any area where the skin looks red, feels tender, or carries visible bruising or a scar. If you notice any persistent lump or firmness under the skin at an injection site, raise it at your next prescriber check-in rather than injecting near it in the meantime. The NHS semaglutide guidance covers the same core points and is a useful plain-English reference alongside your Patient Information Leaflet.

Signs to take seriously: skin reactions and when to seek help

Mild localised reactions (a little redness, temporary tenderness, or slight swelling exactly where the needle went) are common and usually settle within a day or two. They are not a reason to stop treatment, but they are a reason to make sure your technique is sound: a clean site, a fresh needle, the full 90-degree angle, and holding the pen in place for the count recommended in the leaflet.

More significant reactions need attention. Persistent lumps, skin that feels warm or shows spreading redness, or any sign of infection should be reported to your prescriber promptly. Equally, a severe allergic reaction (hives, swelling of the face or throat, difficulty breathing) is a medical emergency; call 999. You can also report any suspected side effect to the MHRA via the Yellow Card scheme, which helps regulators monitor safety across the population.

For a more detailed look at the technique specific to each site (angle, pinch technique, needle depth) the Wegovy injection site guide walks through each location in turn.

Does the site affect how Wegovy works?

This is the question our prescribers hear regularly, and the short answer is: not meaningfully, when technique is correct. Clinical trial data for semaglutide, including the STEP 1 study published in the New England Journal of Medicine, were collected across all three licensed sites with no statistically significant difference in absorption between them. What does influence absorption is the condition of the tissue (hence the rotation advice above) and correct subcutaneous depth, which is why technique matters more than site preference.

If you are also considering how timing interacts with everything else (whether morning or evening makes a difference, or how to handle a week where your usual day falls on a bank holiday) the guide to injection timing covers those questions separately, and our separate guide on when is best to inject Wegovy goes further into how the time of day and weekly schedule can work together. And if you are still weighing up whether Wegovy is the right treatment for you, a look at the weight-loss treatment options gives a broader picture of what is licensed in the UK. For a straightforward comparison with semaglutide injections more generally, injection site guidance for semaglutide covers the same principles across both weight-management and diabetes formulations.

Wegovy is a prescription-only medicine. The information on this page is educational and not a substitute for the advice of your prescriber or the instructions in your Patient Information Leaflet. If you have not yet started treatment and would like to understand whether you are clinically suitable, you can check your eligibility with our prescribers, the consultation is free, with no obligation.